Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Angiotech Pharmaceuticals (ANP.TO)

TOP PICK
Expects health services to lead the market. More angioplasty due to aging population.
WAIT
In competition with J & J on their stents. Expects a lot of news in trials during September.
DON'T BUY
Too speculative. Good balance sheet and lots of cash, but no earnings.
WAIT
Wait for results on tests for coated stents.
TOP PICK
Good biotech. Lots of cash. Have US producers. Excellent mngmnt
Showing 136 to 140 of 140 entries